Skip to main content
Tissue Barriers logoLink to Tissue Barriers
. 2016 Jan 28;4(1):e1143544. doi: 10.1080/21688370.2016.1143544

Heterogeneity of the blood-brain barrier

Imola Wilhelm 1, Ádám Nyúl-Tóth 1, Maria Suciu 2, Anca Hermenean 2, István A Krizbai 1,2,*
PMCID: PMC4836475  PMID: 27141424

ABSTRACT

The brain microvascular network is comprised of capillaries, arterioles and venules, all of which retain – although to a different extent – blood-brain barrier (BBB) properties. Capillaries constitute the largest and tightest microvasculature. In contrast, venules have a looser junctional arrangement, while arterioles have a lower expression of P-gp. Development and maintenance of the BBB depends on the interaction of cerebral endothelial cells with pericytes and astrocytes, which are all heterogeneous in different regions of the central nervous system. At the level of circumventricular organs microvessels are permeable, containing fenestrations and discontinuous tight junctions. In addition, the blood-spinal cord barrier – where the number of pericytes is lower and expression of junctional proteins is reduced – is also more permeable than the BBB. However, much less is known about the cellular, molecular and functional differences among other regions of the brain. This review summarizes our current knowledge on the heterogeneity of the brain microvasculature.

Keywords: astrocytes, blood-brain barrier, blood-spinal cord barrier, cerebral endothelial cells, circumventricular organs, gray and white matter, microvessel, neurovascular unit, pericytes, regional differences

Introduction

The central nervous system (CNS) is separated from the rest of the body by 3 barrier systems (the blood-brain barrier, the blood-cerebrospinal fluid barrier at the choroid plexus and the arachnoid barrier), the most important of which is the blood-brain barrier (BBB). The BBB not only restricts the free transport of different potentially harmful substances to the brain, but plays a critical role in the transport of nutrients to the brain and removal of metabolites.

Anatomically, the BBB is located at the level of the brain microvascular network comprised of capillaries, arterioles and venules. The barrier itself is formed by cerebral endothelial cells (CECs) interconnected by a continuous line of tight junctions (TJs). In addition, an important regulatory role is attributed to pericytes located in the duplication of the basement membrane (for review see refs. 1,2). Cerebral capillaries are surrounded by specialized structures of astrocytes, called endfeet, which cover more than 90% of capillaries, and together with the deposited parenchymal basement membrane form the glia limitans perivascularis. These three cell types – together with neurons – are the main components of the neurovascular unit (NVU).

The barrier functions of CECs include a paracellular barrier (tight junctions/TJs, apical junctional complex), a transcellular barrier (low level of pinocytosis and transcytosis), an enzymatic barrier (enzymes metabolizing biologically active substances including catecholamines, acetylcholine, peptides) and the presence of efflux transporters (ABC transporters).3 Transport of water soluble substances which are not able to cross cell membranes is provided by solute-like carrier transporters (SLCs) or receptor-mediated endocytosis. TJs of CECs are composed of transmembrane proteins like occludin, claudins (mainly claudin-5), junctional adhesion molecules, etc.; and plaque proteins including zonula occludens proteins (ZO-1, ZO-2) and associated molecules. TJs are supported by adherens junctions (AJs), which are mainly formed by cadherin-catenin complexes. In human brain microvessels the most abundantly expressed ABC transporters are ABCG2/BCRP, ABCB1/MDR1, ABCC1, ABCC4, ABCC5, ABCA2 and ABCA8, while the main SLC transporters are SLC2A1/GLUT1, SLC7A5/LAT1, SLC16A1/MCT1, SLC1A3/EAAT1 and SLC1A2/EAAT2.4

Although this general structure and molecular composition is valid for a large part of the CNS, the functional diversity of the brain is reflected by regional differences in BBB function. These differences may not only be present between anatomically distinct regions, but could appear along the vascular tree among the capillary, arteriolar and venular endothelium as well. Although capillaries constitute the largest microvascular surface in the CNS,5 the role of arterioles and venules should not be underestimated. Due mainly to technical reasons (difficulty to isolate endothelial cells from different brain regions or vascular compartments), the cerebral endothelium is often regarded as a homogenous population. However, this simplification may lead to an inadequate understanding of brain microvascular function with potentially significant therapeutic consequences as well.

This review summarizes our present knowledge on the heterogeneity in the structure and function of the NVU.

Morphological differences in the vasculature of different CNS regions

The capillary network of distinct brain regions may show differences in topography, and in the morphology and function of the cells of the NVU. The capillary density is higher in the gray matter than in the white matter, which is thought to be related to the higher synaptic activity and metabolic demand of neurons. In the rat brain the medium distance among capillaries was shown to be 19.5 μm in the gray matter and 29.8 μm in the white matter, and there was a significant difference in capillary surface areas (179 cm2/g vs. 107 cm2/g in the gray vs. the white matter).6 Comparing 18 gray matter and 5 white matter regions in the rat brain, Borowsky and Collins found that the capillary density was 3-5-times higher in gray matter structures than in the white matter, the highest being in the inferior colliculus (Table 1). Regional capillary density showed strong positive correlation with glucose utilization and negative correlation with lactate dehydrogenase (LDH) activity. Cytochrome oxidase activity was lower in the white matter than in the gray matter.7 Density and branching of capillaries was found to be higher in the gray matter than in the corpus callosum in mice as well.8 White matter vessels were found to be oriented parallel to the axons.

Table 1.

Regional differences in the NVU.

  circumventricular organs spinal cord white matter (c. callosum) gray matter (cortex) hippocampus cerebellum
capillary density SFO: high   lower than in gray matter higher than in white matter, increased in deeper cortical regions, AD+aging: decrease CA3: high, CA1=white matter, aging or AD: decrease  
astrocytes GFAP-positive astrocytes: important role in preventing diffusion of blood-derived molecules outside sensory CVOs   most abundant: fibrous, high expression of intermediate filament proteins and CD44, high expression and activity of glutamate transporters most abundant: protoplasmic, high levels of connexin-30, highly coupled CA3: low coupling, CA1: highly coupled astrocytes  
pericytes high NG2 and PDGFRβ expression lower pericyte coverage, ALS: pericyte loss   high pericyte coverage, AD: pericyte loss high pericyte coverage, AD: pericyte loss and dissociation  
cerebral endothelial cells fenestrated capillaries, thinner endothelial cells, vesicles, discontinuous TJs, low expression of TJ proteins, high permeability (higher in the central regions) reduced amounts of ZO-1, occludin, β-catenin, VE-cadherin and P-gp than in brain endothelial cells, increased permeability as compared with the brain basement membrane=as in gray matter, CD44-negative endothelial cells, lower P-gp expression in the epileptogenic temporal lobe, increased permeability in MS basement membrane=as in white matter, medium-sized arterioles: CD44-positive, high P-gp expression and activity increased permeability in response to histamin, during aging, in pancreatitis or epilepsia compared to cortex, CA3: less permeable in ischemia or during aging than CA1 lower P-gp expression than in the cortex, more permeable (to bilirubin, in response to histamin) than cortical regions

Even within the gray matter large differences were observed in the vascular density of different regions. In the mouse cortex relatively few capillaries were found immediately below the glia limitans, but capillary density increased in deeper cortical regions to an apparent maximum near 500 μm below the surface of the somatosensory cortex (Table 1).9 The rat hippocampal CA3 region was shown to be rich in microvessels, similar to the parietal or the frontal cortical regions. On the other hand, the CA1 region was shown to have a low vascular density, comparable to the corpus callosum (Table 1).10 The capillary density of the subfornical organ (SFO) (one of the circumventricular organs with increased BBB permeability) and of the inferior colliculus (a metabolically very active part of the brain) was even higher than that of the sensorimotor cortex in rats.11 In the mouse brain the best vascularized regions were found to be the colliculi, thalamus, parietal cortex and occipital cortex, while the worst vascularized regions were the pons and medulla.12

Pathological processes may differently affect vascular densities of different CNS regions. In mouse models both aging and Alzheimer's disease (AD) were shown to contribute to the decrease in vessel densities in the hippocampus, while in the cortex loss of microvascularization was a consequence of the interaction of aging and AD (Table 1).13 It has also been shown that during aging different angiogenesis-related genes were altered in distinct brain regions of the mouse. Although VEGF was not altered, several other factors were found to be differently regulated (e.g. MMP-2 decreased in the cortex, but increased in the white matter of old animals). It was concluded that regional control of multiple angiogenesis-related genes exists in the brain.8 Although aging induced capillary loss in all brain regions, the severity of this process was higher in the gray matter than in the white matter, while reduction of capillary branch points affected the cortex and the white matter, but not the hippocampus.8 Physical exercise reversed some aging-associated impairment of angiogenesis-related gene expression in all 3 brain regions studied. On the other hand, it positively impacted brain capillary density and branching in aged mice only in the hippocampus, but not in the cortex or the corpus callosum.8

Differences in astrocytes

In respect of the cellular differences in different CNS regions, out of the 3 most important cell types of the BBB/NVU astrocytes were shown to be the most diverse. They differ in their origin, function, density and morphology, possibly adapting to the needs of their environment.14 The most abundant astrocyte types are protoplasmic astrocytes in the gray matter and fibrous astrocytes in the white matter (Table 1).15 They have different morphologies: protoplasmic astrocytes having several radially extending processes, while fibrous astrocytes having smoother, longer processes. It has been shown that white matter astrocytes have higher levels of intermediate filament proteins (including GFAP, vimentin and nestin) than gray matter astroglial cells (Table 1).14 Moreover, cultured astrocytes derived from the white matter were found to have increased levels of SLC1A3 (GLAST1/EAAT1), SLC1A2 (GLT1/EAAT2) and glutamine synthetase (GS) in comparison with astrocytes originating from the gray matter (Table 1).16

The cell surface molecule CD44 was found to be predominantly expressed on the surface of white matter astrocytes (Table 1).17 In the gray matter CD44 was found to be associated with the processes of some astrocytes of both protoplasmic and fibrous morphology, which came in association with blood vessels.18 Interestingly, CD44 can be upregulated during aging 18 and CNS disorders including multiple sclerosis/MS 19 and AD.18

In addition, intercellular communication of astrocytes may differ in distinct regions of the CNS. Regional differences exist in the connexin expression of astrocytes, e.g., white matter astrocytes have no or less connexin-30 levels than gray matter astrocytes (Table 1).20 Astrocytes in the neocortex were found to be highly coupled, in contrast to astrocytes in the corpus callosum. As a consequence, astrocytic calcium waves were shown to propagate without gap junctional coupling in the white matter, while in the neocortex calcium wave propagation depended on functional astrocytic gap junctions.21 In the hippocampus CA1 astrocytes were shown to have a high degree of cell-to-cell coupling, while in CA3 astrocytes' coupling was absent or restricted to smaller cell groups (Table 1).22

Although the differences in astrocyte morphology and function are well characterized, little is known about their impact on BBB function. The importance of GFAP – which shows regional differences in its expression – in the formation of the BBB is supported by the findings that lack of GFAP impairs the integrity of the BBB 23 and GFAP-deficient astrocytes have a reduced capacity to induce BBB properties.24 Moreover, it has been suggested that reduced GFAP expression in the endfeet of astrocytes might contribute to the fragility of the germinal matrix vasculature, and therefore might play an important role in the pathogenesis of intraventricular hemorrhages of premature infants.25

Since astrocytes are indispensable in the maintenance of the barrier function of CECs, differences in astrocyte functions might influence the BBB as well. Further studies are needed to understand how astrocytes of different type in different CNS regions influence the BBB in physiological conditions. On the other hand, it is well known that in neurological disorders (ischemia, brain trauma, brain tumors, epilepsy, Parkinson's Disease/PD or AD) reactive astrogliosis occurs during BBB disruption (for review and further information see ref. 26).

Regional differences in pericytes

Pericytes are also very diverse in their origin and have important regulatory functions on different endothelial functions.2 Pericyte coverage of brain capillaries was shown to be ˜80% in the mouse cortex, caudate nucleus and hippocampus.27 On the other hand, pericyte coverage was significantly lower (varying between 48 and 68%) in cervical, thoracic, and lumbar spinal cord anterior horn capillaries in comparison to the brain, but not (or to a lesser extent) in the white matter regions of the spinal cord (Table 1).27 Lower pericyte coverage was shown to correlate with the higher permeability of the blood-spinal cord barrier (BSCB) in comparison to the BBB.27 In amyotrophic lateral sclerosis, a motor neuron disease of the spinal cord, a reduction in the number of pericytes was demonstrated correlating with an increase in the permeability of the BSCB.28

In circumventricular organs, pericytes were shown to express high levels of NG2 and PDGFRβ, as seen in the immature vasculature (Table 1). Chronic salt loading caused a further increase of pericytic expression of NG2 and PDGFRβ, and increased vascular permeability of FITC in the organum vasculosum laminae terminalis and the SFO.29

In the hippocampus (a region critical for learning and memory) age-dependent BBB breakdown was shown to correlate with pericyte injury.30 In AD a significant loss of pericytes was observed in both the hippocampus and the frontal cortex, correlating with BBB leakage.31 In mice with AD-like pathology loss of pericytes was observed in both the cortex and the hippocampus, while progressive perivascular dissociation of pericytes was characteristic to the hippocampus, but no to the cortex (Table 1).13

In conclusion, the extent of pericyte coverage seems to directly influence the barrier function of CECs in different brain regions in physiological and pathological conditions as well.

Differences in cerebral endothelial cells

CECs are the most important cellular components of the BBB; therefore, differences in barrier properties of capillaries in different brain regions are directly determined by the properties of endothelial cells. However, little is known about the heterogeneity of BBB-forming endothelial cells.

The BBB is localized to the level of microvascular endothelial cells, which comprise not only capillaries (vessels <10 μm diameter) but also arterioles and venules (which are 10–100 μm in size). Arterial and venous endothelial cells differently express ephrinB2 and EphB4, several members of Notch signaling, Hedgehog morphogens and VEGF-A 32 – all of which have important role in the regulation of BBB functions. To our best knowledge, however, the regional distribution and function of these proteins in different brain microvascular segments have not been studied so far.

Indeed, CECs are not homogenous all over the microvasculature and this heterogeneity is reflected in their functional diversity. By profiling 87 genes enriched in brain microvessels it was shown that most of the BBB properties reside in both capillaries and venules, but particular functions may specifically associate with different segments. Solute transport seems to be preferentially related to capillaries, while venules showed higher expression of inflammation-associated genes (Table 2).33

Table 2.

Heterogeneity of the BBB in different segments of the brain microvasculature.

  arterioles capillaries venules
gene expression   increased expression of genes of the solute transport system higher expression of inflammation-associated genes
TJs     looser arrangement of junctional strands than in capillaries, EAE: loss of claudin-5
transporters lower P-gp levels high and uniform P-gp levels high and uniform P-gp levels
astrocytic endfeet thickest astrocytic perivascular sheaths GFAP-negative astrocytic processes, highest density of contacting processes, thinest astrocytic perivascular sheaths  

Biochemical and physiological properties related to the barrier functions of endothelial cells seem to be more expressed in capillaries than in larger microvessels. These characteristics include expression of specific transporters (P-gp, Glut-1), receptors (transferrin receptor) and enzymatic activities (e.g., alkaline phosphatase) (reviewed in ref. 34). Postcapillary venules were shown to have looser arrangement of junctional strands than capillaries (Table 2),35 being therefore the preferred site for leukocyte extravasation. In the thoraco-lumbar spinal cord of mice the intensity of immunostaining for claudin-5 – which forms the backbone of the TJs – was highest in the capillaries and smaller venules, and lowest in the larger venules. During experimental autoimmune encephalitis (EAE), claudin-5 was shown to be selectively lost in venules with permeability increase in both capillaries and venules (Table 2).36 In the human brain P-gp/ABCB1 was found to be localized to the luminal membrane of microvessel endothelial cells, becoming weaker or undetectable on larger vessels.37 Its expression displayed an increasing gradient from an almost undetectable level in large penetrating arterioles to a high and uniform level in capillaries and venules (Table 2).38 It was suggested that the lower expression of P-gp in arterioles in comparison to capillaries and venules could participate in the preferential arteriolar accumulation of β-amyloid in cerebral amyloid angiopathy.

It has also been shown that differences exist in the glio-vascular interface along the microvasculature. In the rat cortex the surfaces of large to medium-size vessels were densely covered by GFAP-positive astrocytic end-feet; however, astrocytic processes covering capillaries were found to be GFAP-negative (Table 2).39 In addition, arteries were found to have the thickest astrocytic perivascular sheaths, followed by veins, while capillaries had the thinnest astrocytic perivascular sheaths. The highest density of contacting processes was found for capillaries (Table 2).9

Regarding BBB differences in different brain regions, it is important to understand endothelial heterogeneity in the distinct parts of the CNS. No differences were found between the white and gray matters in the composition of the basement membrane in the cerebral vasculature of human fetuses, premature and mature infants.40 On the other hand, the adhesion molecule CD44 was found on endothelial cells of medium-sized arterioles in the gray matter but, not in the white matter (Table 1).17

Using a mouse model expressing human MDR1-luc, both hMDR1 transcription and mouse P-gp protein expression were found to be higher in the cortex than in the cerebellum (Table 1).41 In the removed brain tissues of the epileptogenic temporal lobe higher P-gp expression was found in capillaries of the gray matter than in the white matter. Seizure recurrence coincided with higher P-gp expression, especially in the white matter, of the resected lobe.42

Barrier properties of CECs, however, principally depend on the TJs. Differences in the permeability of the BBB are mainly a consequence of the differences in the TJs, which are responsible for the first defense line (i.e. the paracellular barrier) of CECs. Regional differences in TJs and BBB permeability are discussed in the next chapter.

Fuctional differences: Permeability properties of the BBB in different brain regions. Role of tight junctions

The barrier function of the BBB is reflected by its relative impermeability to blood-borne solutes. Due to the presence of a complex network of TJ strands, the intact BBB prevents the diffusion of hydrophilic tracers into the CNS parenchyma. Size-selective opening or permeability differences can be monitored using fluorescent tracers (sodium fluorescein – 376 Da, fluorescein isothiocyanate/FITC – 389 Da, Lucifer yellow – 457 Da or fluorescently labeled dextrans – 3–70 kDa) or radiolabeled compounds (e.g., 3H-mannitol – 180 Da, 3H-sucrose – 342 Da, 3H/14C-inulin – ∼5 kDa). Flux of tracers can be assessed both in vivo and in vitro. Ion permeability of TJs can be estimated in vitro by measuring the transendothelial electrical resistance (TEER). Both TEER and permeability measurements reflect not only the paracellular pathway, but a composite of the para- and the transcellular routes.43 The transcellular route is mainly reflected by the flux of Evans blue-labeled albumin (66 kDa) or horseradish peroxidase (44 kDa).

The most striking functional differences in BBB permeability are associated to circumventricular organs (CVOs). Here the BBB is leaky and the capillaries are fenestrated, allowing a relatively free exchange of substances between the blood and CNS. CVOs are important elements of the neuroendocrine system and include the area postrema (AP), the subfornical organ (SFO) and the organum vasculosum laminae terminalis (OVLT) (these regions are capable of sensing the concentration of different peptides), the pineal gland, the posterior pituitary, the intermediate lobe of the pituitary gland, the median eminence and the subcommissural organ (which are secretory organs). Morphologically here the capillaries are fenestrated with discontinuous TJs, thinner endothelial cells which contain more vesicles than capillaries of other brain regions (Table 1).44 Although the exchange of circulating substances is relatively free in the CVOs, they do not provide direct passage of blood-borne substances to the rest of the brain due to the presence of diffusion barriers. For example, ZO-1- and GFAP-positive columnar cells were described between the AP and nucleus tractus solitarius.45 Both the outer basement membrane and also astrocytes and tanycytes are considered alternative barriers to prevent diffusion of blood-derived molecules outside the sensory CVOs.46

However, not even the endothelia of CVO microvessels constitute a homogenous population. In the median eminence and the SFO many capillaries lack detectable levels of ZO-1; low level of ZO-1 can be detected in the AP, but in the subcommissural organ the ZO-1 staining is similar to barrier forming capillaries.47 In the SFO the blood-to-tissue flux of 14C-α-aminoisobutyric acid was shown to be 100–400 times faster than in the gray or the white matter 11 and the water permeability was shown to be one of the highest in the brain.48 The AP region could be clearly localized in living humans by SF administration,49 indicating the permeability of the AP to the dye.

In addition, sensory CVOs of mouse capillaries were found to be permeable to FITC and to 3 kDa dextran; however, the 10 kDa dextran remained in the perivascular space between the inner and outer basement membranes. Interestingly, not even the lower molecular weight markers were able to diffuse beyond the dense network of GFAP-positive astrocytes and tanycytes, which have a higher density at distal subdivisions of the sensory CVOs as compared with central subdivisions (capillary plexus in the OVLT, the ventromedial core in the SFO and the central zone in the AP). It is important to note that the capillary permeability was higher in the central regions of secretory CVOs (Table 1). In line with these findings, TJ proteins like occludin, claudin-5 and ZO-1 were undetectable at the central subdivisions, whereas a low level of staining was detectable in distal subdivisions.46

Although the rest of the CNS is protected by an intact BBB under physiological conditions, its permeability is not uniform. The most important differences are related to the spinal cord. The blood-spinal cord barrier (BSCB) has a similar cellular and molecular structure as the BBB; however, specific differences have been described. Literature data indicate that in general the BSCB has an increased permeability to 3H-mannitol and 14C-inulin in comparison to the BBB, the lumbar cord appearing to be the most permeable (Table 1).50 Cultured rat endothelial cells isolated from the spinal cord reached lower TEER values than endothelial cells isolated from rat brains; however, both showed similarly low permeability to Lucifer yellow.51 In the murine spinal cord – predominantly in the anterior horn – the number and capillary coverage of pericytes was found to be reduced as compared with the brain, leading to decreased expression of occludin and ZO-1, but not of claudin-5 in spinal cord capillaries. As a consequence, increased permeability to 350 Da-150 kDa tracers was observed in the cervical, thoracic and lumbar spinal cord regions when compared to the brain.27 In accordance, murine spinal cord microvascular endothelial cells in culture were shown to express reduced amounts of ZO-1, occludin, β-catenin, VE-cadherin and P-gp than brain endothelial cells (Table 1).52 The differences between the 2 barrier systems, i.e., the BBB and the BSCB, might be responsible for some of the differences between the pathologies of the brain and the spinal cord.53

Permeability differences have been described among different regions of the BBB-protected brain as well, mainly in non-physiological conditions. Multiple sclerosis patients, for instance, were shown to have increased BBB permeability in the total white matter, but not in gray matter regions.30 In 2-day old piglets the brainstem and the cerebellum were shown to be more permeable (at least to bilirubin) than cortical regions.54 In response to the histamine antagonist DPPE, an increased permeability for sodium fluorescein was seen in the hippocampus, striatum and cerebellum, but not in the parietal cortex of rats, while Evans blue-labeled albumin extravasated in all brain regions.55 The rat parietal cortex was also found to be more resistant to acute pancreatitis-induced BBB permeability increase than the hippocampus, striatum and medulla (Table 1).56 In ischemic conditions extravasation of albumin was shown to be more pronounced in the hippocampal CA1 region than in the highly vascularised CA3 region of the rat brain (Table 1).10 After status epilepticus induced in rats, BBB leakage was observed only in limbic brain regions (in the entorhinal cortex, amygdala and the piriform cortex, and to a lower extent in the hippocampus and thalamus), while cortical brain regions such as the motor cortex were not affected. BBB impairment was still present 6 weeks after staus epilepticus in the hippocampus, entorhinal cortex, amygdala and piriform cortex.57

Aging and hormonal status may also differently influence the BBB of different brain regions. Increased IgG leakage was observed in the hippocampus and thalamus, but not the hypothalamus of reproductive senescent female rats.58 In the aging human brain a progressive leakage through the BBB was observed in the hippocampus (the CA1 and DG, but not the CA3 region) (Table 1) and the caudate nucleus, but other brain regions (frontal cortex, temporal cortex, thalamus, striatum, subcortical white matter fibers, corpus callosum and internal capsule) were not affected.30 The process affected persons with no cognitive impairment, but was accelerated in cognitively impaired individuals.

Taken together, pathological processes of specific brain regions are usually associated with BBB impairment of the region affected. However, interventional approaches may also differently affect the BBB of diverse CNS regions. Systemically-injected reduced graphene oxide, for example, was found to induce a transient opening of the BBB mainly in the thalamus and hippocampus of rats.59

Conclusions

The largest part of the CNS is protected by a tight BBB composed of CECs interconnected by continuous TJs. At the level of circumventricular organs – especially in their central regions – capillaries are more permeable, containing fenestrations and discontinuous TJs. However, other CNS regions are also heterogenous in the tightness of the barrier. In special, the blood-spinal cord barrier (BSCB) was shown to be more permeable than the BBB. This is in line with the reduced expression of TJ proteins and the lower number of pericytes covering the outer surface of capillaries. However, much less is known about the permeability differences among other regions of the brain in physiological conditions. Considering the regional restriction of several brain pathologies and the diversity of astrocytes, it is to be expected that the NVU is not uniform throughout the brain. Further studies are needed to understand differences in brain endothelial properties in the white matter, cortex, hippocampus, cerebellum, etc. Regional NVU differences are summarized in Table 1.

Moreover, heterogeneity of CECs appears among capillary, arteriolar and venular segments as well, which are all parts of the BBB. Barrier properties seem to be more expressed in capillaries than in larger microvessels (Table 2).

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Funding

The work of I.A.K. and I.W. is financed by the Hungarian Scientific Research Grant (OTKA K-100807, K-116158 and PD-100958). M.S. was financed by the strategic grant POSDRU/159/1.5/S/133391 within the project “Doctoral and post-doctoral programs of excellence for highly qualified human resources training for research in the field of Life sciences, Environment and Earth Science” co-financed by the European Social Fund within the Sectorial Operational Program Human Resources Development 2007 – 2013.

References

  • 1.Hill J, Rom S, Ramirez SH, Persidsky Y. Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease. J Neuroimmune Pharmacol 2014; 9:591-605; PMID:25119834; http://dx.doi.org/ 10.1007/s11481-014-9557-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci 2011; 14:1398-405; PMID:22030551; http://dx.doi.org/ 10.1038/nn.2946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wilhelm I, Krizbai IA. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Mol Pharm 2014; 11:1949-63; PMID:24641309; http://dx.doi.org/ 10.1021/mp500046f [DOI] [PubMed] [Google Scholar]
  • 4.Shawahna R, Uchida Y, Declèves X, Ohtsuki S, Yousif S, Dauchy S, Jacob A, Chassoux F, Daumas-Duport C, Couraud PO, et al.. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 2011; 8:1332-41; PMID:21707071; http://dx.doi.org/ 10.1021/mp200129p [DOI] [PubMed] [Google Scholar]
  • 5.Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/ 10.1038/nrn1824 [DOI] [PubMed] [Google Scholar]
  • 6.Schlageter KE, Molnar P, Lapin GD, Groothuis DR. Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc Res 1999; 58:312-28; PMID:10527772; http://dx.doi.org/ 10.1006/mvre.1999.2188 [DOI] [PubMed] [Google Scholar]
  • 7.Borowsky IW, Collins RC. Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J Comp Neurol 1989; 288:401-13; PMID:2551935; http://dx.doi.org/ 10.1002/cne.90288-0304 [DOI] [PubMed] [Google Scholar]
  • 8.Murugesan N, Demarest TG, Madri JA, Pachter JS. Brain regional angiogenic potential at the neurovascular unit during normal aging. Neurobiol Aging 2012; 33:1004.e1-16; PMID:22019053; http://dx.doi.org/ 10.1016/j.neurobio-laging.2011.09.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.McCaslin AF, Chen BR, Radosevich AJ, Cauli B, Hillman EM. In vivo 3D morphology of astrocyte-vasculature interactions in the somatosensory cortex: implications for neurovascular coupling. J Cereb Blood Flow Metab 2011; 31:795-806; PMID:21139630; http://dx.doi.org/ 10.1038/jcbfm.2010.204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cavaglia M, Dombrowski SM, Drazba J, Vasanji A, Bokesch PM, Janigro D. Regional variation in brain capillary density and vascular response to ischemia. Brain Res 2001; 910:81-93; PMID:11489257; http://dx.doi.org/ 10.1016/S0006-8993(01)02637-3 [DOI] [PubMed] [Google Scholar]
  • 11.Gross PM, Sposito NM, Pettersen SE, Fenstermacher JD. Differences in function and structure of the capillary endothelium in gray matter, white matter and a circumventricular organ of rat brain. Blood Vessels 1986; 23:261-70; PMID:3790742 [DOI] [PubMed] [Google Scholar]
  • 12.Zhao R, Pollack GM. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain. Biochem Pharmacol 2009; 78:1052-9; PMID:19523457; http://dx.doi.org/ 10.1016/j.bcp.2009.06.001 [DOI] [PubMed] [Google Scholar]
  • 13.Janota CS, Brites D, Lemere CA, Brito MA. Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice. Brain Res 2015; 1620:153-68; PMID:25966615; http://dx.doi.org/ 10.1016/j.brainres.2015.04.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lundgaard I, Osório MJ, Kress BT, Sanggaard S, Nedergaard M. White matter astrocytes in health and disease. Neuroscience 2014; 276:161-73; PMID:24231735; http://dx.doi.org/ 10.1016/j.neuroscience.2013.10.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Reichenbach A, Wolburg H. Astrocytes and ependymal glia In: Kettenmann H, Ransom BR, eds. Neuroglia. United States of America: Oxford University Press, 2013:35-50. [Google Scholar]
  • 16.Goursaud S, Kozlova EN, Maloteaux JM, Hermans E. Cultured astrocytes derived from corpus callosum or cortical gray matter show distinct glutamate handling properties. J Neurochem 2009; 108:1442-52; PMID:19222709; http://dx.doi.org/ 10.1111/j.1471-4159.2009.05889.x [DOI] [PubMed] [Google Scholar]
  • 17.Kaaijk P, Pals ST, Morsink F, Bosch DA, Troost D. Differential expression of CD44 splice variants in the normal human central nervous system. J Neuroimmunol 1997; 73:70-6; PMID:9058761; http://dx.doi.org/ 10.1016/S0165-5728(96)00167-1 [DOI] [PubMed] [Google Scholar]
  • 18.Akiyama H, Tooyama I, Kawamata T, Ikeda K, McGeer PL. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease. Brain Res 1993; 632:249-59; PMID:7511977; http://dx.doi.org/ 10.1016/0006-8993(93)91160-T [DOI] [PubMed] [Google Scholar]
  • 19.Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Moscarello MA. Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol 1991; 50:779-92; PMID:1748883; http://dx.doi.org/ 10.1097/00005072-199111000-00009 [DOI] [PubMed] [Google Scholar]
  • 20.Nagy JI, Rash JE. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 2000; 32:29-44; PMID:10751655; http://dx.doi.org/ 10.1016/S0165-0173(99)00066-1 [DOI] [PubMed] [Google Scholar]
  • 21.Haas B, Schipke CG, Peters O, Söhl G, Willecke K, Kettenmann H. Activity-dependent ATP-waves in the mouse neocortex are independent from astrocytic calcium waves. Cereb Cortex 2006; 16:237-46; PMID:15930372; http://dx.doi.org/ 10.1093/cercor/bhi101 [DOI] [PubMed] [Google Scholar]
  • 22.D'Ambrosio R, Wenzel J, Schwartzkroin PA, McKhann GM, Janigro D. Functional specialization and topographic segregation of hippocampal astrocytes. J Neurosci 1998; 18:4425-38; PMID:9614220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996; 17:607-15; PMID:8893019; http://dx.doi.org/ 10.1016/S0896-6273(00)80194-4 [DOI] [PubMed] [Google Scholar]
  • 24.Pekny M, Stanness KA, Eliasson C, Betsholtz C, Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 1998; 22:390-400; PMID:9517571; http://dx.doi.org/ 10.1002/(SICI)1098-1136(199804)22:4%3c390::AID-GLIA8%3e3.0.CO;2-7 [DOI] [PubMed] [Google Scholar]
  • 25.Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010; 67:1-8; PMID:19816235; http://dx.doi.org/ 10.1203/PDR.0b013e3-181c1b176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alvarez JI, Katayama T, Prat A. Glial influence on the blood brain barrier. Glia 2013; 61:1939-58; PMID:24123158; http://dx.doi.org/ 10.1002/glia.22575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Winkler EA, Sengillo JD, Bell RD, Wang J, Zlokovic BV. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab 2012; 32:1841-52; PMID:22850407; http://dx.doi.org/ 10.1038/jcbfm.2012.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 2013; 125:111-20; PMID:22941226; http://dx.doi.org/ 10.1007/s00401-012-1039-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Morita S, Hourai A, Miyata S. Changes in pericytic expression of NG2 and PDGFRB and vascular permeability in the sensory circumventricular organs of adult mouse by osmotic stimulation. Cell Biochem Funct 2014; 32:51-61; PMID:23629811; http://dx.doi.org/ 10.1002/cbf.2971 [DOI] [PubMed] [Google Scholar]
  • 30.Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, et al.. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015; 85:296-302; PMID:25611508; http://dx.doi.org/ 10.1016/j.neuron.2014.12.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 2013; 23:303-10; PMID:23126372; http://dx.doi.org/ 10.1111/bpa.12004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009; 104:576-88; PMID:19286613; http://dx.doi.org/ 10.1161/CIRCRESA-HA.108.188805 [DOI] [PubMed] [Google Scholar]
  • 33.Macdonald JA, Murugesan N, Pachter JS. Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. J Neurosci Res 2010; 88:1457-74; PMID:20025060 [DOI] [PubMed] [Google Scholar]
  • 34.Ge S, Song L, Pachter JS. Where is the blood-brain barrier … really? J Neurosci Res 2005; 79:421-7; PMID:15635601; http://dx.doi.org/ 10.1002/jnr.20313 [DOI] [PubMed] [Google Scholar]
  • 35.Nagy Z, Peters H, Hüttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest 1984; 50:313-22; PMID:6422163 [PubMed] [Google Scholar]
  • 36.Paul D, Cowan AE, Ge S, Pachter JS. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. Microvasc Res 2013; 86:1-10; PMID:23261753; http://dx.doi.org/ 10.1016/j.mvr.2012.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Virgintino D, Robertson D, Errede M, Benagiano V, Girolamo F, Maiorano E, Roncali L, Bertossi M. Expression of P-glycoprotein in human cerebral cortex microvessels. J Histochem Cytochem 2002; 50:1671-6; PMID:12486090; http://dx.doi.org/ 10.1177/002215540205001212 [DOI] [PubMed] [Google Scholar]
  • 38.Saubaméa B, Cochois-Guégan V, Cisternino S, Scherrmann JM. Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab 2012; 32:81-92; http://dx.doi.org/ 10.1038/jcbfm.2011.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M. Signaling at the gliovascular interface. J Neurosci 2003; 23:9254-62; PMID:14534260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Xu H, Hu F, Sado Y, Ninomiya Y, Borza DB, Ungvari Z, Lagamma EF, Csiszar A, Nedergaard M, Ballabh P. Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J Neurosci Res 2008; 86:1482-500; PMID:18214989; http://dx.doi.org/ 10.1002/jnr.21618 [DOI] [PubMed] [Google Scholar]
  • 41.Yasuda K, Cline C, Lin YS, Scheib R, Ganguly S, Thirumaran RK, Chaudhry A, Kim RB, Schuetz EG. In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice. Drug Metab Dispos 2015; 43:1646-54; PMID:26281846; http://dx.doi.org/ 10.1124/dmd.115.065078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kwan P, Li HM, Al-Jufairi E, Abdulla R, Gonzales M, Kaye AH, Szoeke C, Ng HK, Wong KS, O'Brien TJ. Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy. Neurobiol Dis 2010; 39:192-7; PMID:20403441; http://dx.doi.org/ 10.1016/j.nbd.2010.04.006 [DOI] [PubMed] [Google Scholar]
  • 43.Matter K, Balda MS. Functional analysis of tight junctions. Methods 2003; 30:228-34; PMID:12798137; http://dx.doi.org/ 10.1016/S1046-2023(03)00029-X [DOI] [PubMed] [Google Scholar]
  • 44.Coomber BL, Stewart PA. Morphometric analysis of CNS microvascular endothelium. Microvasc Res 1985; 30:99-115; PMID:4021842; http://dx.doi.org/ 10.1016/0026-2862(85)90-042-1 [DOI] [PubMed] [Google Scholar]
  • 45.Wang QP, Guan JL, Pan W, Kastin AJ, Shioda S. A diffusion barrier between the area postrema and nucleus tractus solitarius. Neurochem Res 2008; 33:2035-43; PMID:18373195; http://dx.doi.org/ 10.1007/s11064-008-9676-y [DOI] [PubMed] [Google Scholar]
  • 46.Morita S, Furube E, Mannari T, Okuda H, Tatsumi K, Wanaka A, Miyata S. Heterogeneous vascular permeability and alternative diffusion barrier in sensory circumventricular organs of adult mouse brain. Cell Tissue Res 2016 Feb;363(2):497-511; http://dx.doi.org/ 10.1007/s00441-015-2207-7 [DOI] [PubMed] [Google Scholar]
  • 47.Petrov T, Howarth AG, Krukoff TL, Stevenson BR. Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS. Brain Res Mol Brain Res 1994; 21:235-46; PMID:8170348; http://dx.doi.org/ 10.1016/0169-328X(94)90254-2 [DOI] [PubMed] [Google Scholar]
  • 48.Seo Y, Takamata A, Ogino T, Morita H, Nakamura S, Murakami M. Water permeability of capillaries in the subfornical organ of rats determined by Gd-DTPA(2-) enhanced 1H magnetic resonance imaging. J Physiol 2002; 545:217-28; PMID:12433962; http://dx.doi.org/ 10.1113/jphysiol.2002.027227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Longatti P, Porzionato A, Basaldella L, Fiorindi A, De Caro P, Feletti A. The human area postrema: clear-cut silhouette and variations shown in vivo. J Neurosurg 2015; 122:989-95; PMID:25594320; http://dx.doi.org/ 10.3171/2014.11.JNS14482 [DOI] [PubMed] [Google Scholar]
  • 50.Prockop LD, Naidu KA, Binard JE, Ransohoff J. Selective permeability of [3H]-D-mannitol and [14C]-carboxyl-inulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J Spinal Cord Med 1995; 18:221-6; PMID:8591066 [DOI] [PubMed] [Google Scholar]
  • 51.Watson PM, Paterson JC, Thom G, Ginman U, Lundquist S, Webster CI. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci 2013; 14:59; PMID:23773766; http://dx.doi.org/ 10.1186/1471-2202-14-59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ge S, Pachter JS. Isolation and culture of microvascular endothelial cells from murine spinal cord. J Neuroimmunol 2006; 177:209-14; PMID:16806499; http://dx.doi.org/ 10.1016/j.jneuroim.2006.05.012 [DOI] [PubMed] [Google Scholar]
  • 53.Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol 2011; 70:194-206; PMID:21674586; http://dx.doi.org/ 10.1002/ana.22421 [DOI] [PubMed] [Google Scholar]
  • 54.Lee PD, Hintz RL, Sperry JB, Baxter RC, Powell DR. IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Res 1989; 26:308-15; PMID:2552387; http://dx.doi.org/ 10.1203/00006450-198910000-00005 [DOI] [PubMed] [Google Scholar]
  • 55.Deli MA, Németh L, Falus A, Abrahám CS. Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat. Eur J Pharmacol 2000; 387:63-72; PMID:10633162; http://dx.doi.org/ 10.1016/S0014-2999(99)00796-7 [DOI] [PubMed] [Google Scholar]
  • 56.Farkas G, Márton J, Nagy Z, Mándi Y, Takács T, Deli MA, Abrahám CS. Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett 1998; 242:147-50; PMID:9530927; http://dx.doi.org/ 10.1016/S0304-3940(98)00060-3 [DOI] [PubMed] [Google Scholar]
  • 57.van Vliet EA, Otte WM, Gorter JA, Dijkhuizen RM, Wadman WJ. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study. Neurobiol Dis 2014; 63:74-84; PMID:24321435; http://dx.doi.org/ 10.1016/j.nbd.2013.11.019 [DOI] [PubMed] [Google Scholar]
  • 58.Bake S, Friedman JA, Sohrabji F. Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc Res 2009; 78:413-24; PMID:19591848; http://dx.doi.org/ 10.1016/j.mvr.2009.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Mendonça MC, Soares ES, de Jesus MB, Ceragioli HJ, Ferreira MS, Catharino RR, da Cruz-Höfling MA. Reduced graphene oxide induces transient blood-brain barrier opening: an in vivo study. J Nanobiotechnol-ogy 2015; 13:78; http://dx.doi.org/ 10.1186/s12951-015-0143-z [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Tissue Barriers are provided here courtesy of Taylor & Francis

RESOURCES